Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling

KRAS is one of the most frequently mutated oncogenes and a major target in anticancer drug discovery, but small molecule modulators that work in the clinic have been elusive; here a new approach to target KRAS is described, based on interfering with its binding to the prenyl-binding protein PDEδ. In...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 2013-05, Vol.497 (7451), p.638-642
Main Authors: Zimmermann, Gunther, Papke, Björn, Ismail, Shehab, Vartak, Nachiket, Chandra, Anchal, Hoffmann, Maike, Hahn, Stephan A., Triola, Gemma, Wittinghofer, Alfred, Bastiaens, Philippe I. H., Waldmann, Herbert
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!